John Dunn - Accuray Incorporated Chief President
| ARAY Stock | USD 2.23 0.12 5.69% |
President
John Dunn is Chief President of Accuray Incorporated
| Address | 1240 Deming Way, Madison, WI, United States, 53717-1954 |
| Phone | 608 824 2800 |
| Web | https://www.accuray.com |
John Dunn Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Dunn against Accuray Incorporated stock is an integral part of due diligence when investing in Accuray Incorporated. John Dunn insider activity provides valuable insight into whether Accuray Incorporated is net buyers or sellers over its current business cycle. Note, Accuray Incorporated insiders must abide by specific rules, including filing SEC forms every time they buy or sell Accuray Incorporated'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Dunn over six months ago Disposition of 1018 shares by John Dunn of Shyft at 12.42 subject to Rule 16b-3 | ||
John Dunn over six months ago Disposition of 3768 shares by John Dunn of Shyft at 10.44 subject to Rule 16b-3 | ||
John Dunn over six months ago Acquisition by John Dunn of 4545 shares of Shyft at 11.0 subject to Rule 16b-3 |
Accuray Incorporated Management Efficiency
Return On Capital Employed is likely to rise to 0 in 2024, whereas Return On Tangible Assets are likely to drop (0.04) in 2024. At this time, Accuray Incorporated's Other Current Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 8.99 in 2024, whereas Total Assets are likely to drop slightly above 394.4 M in 2024. Accuray Incorporated's management efficiency ratios could be used to measure how well Accuray Incorporated manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Angelo Scopelianos | Axogen Inc | 68 | |
| Erick DeVinney | Axogen Inc | 48 | |
| Michael Greiner | Avanos Medical | 51 | |
| Moshe Citronowicz | Apyx Medical | 71 | |
| Kimberley Elting | Orthofix Medical | 59 | |
| Carlton Reckling | Si Bone | 62 | |
| MBAMSHA CHE | Orthopediatrics Corp | 52 | |
| David Bailey | Orthopediatrics Corp | 45 | |
| Kevin Kenny | Orthofix Medical | 59 | |
| Daniel Gerritzen | Orthopediatrics Corp | 54 | |
| D Lee | Artivion | 56 | |
| Jon Serbousek | Orthofix Medical | 63 | |
| Todd Hornsby | Apyx Medical | 47 | |
| Michael Karavitis | Cutera Inc | 54 | |
| Scott Yerby | Si Bone | 56 | |
| Vincent MS | Cytosorbents Crp | 66 | |
| William Haydon | Avanos Medical | 57 | |
| Gregory Odle | Orthopediatrics Corp | 54 | |
| David Ball | Avanos Medical | 65 | |
| Arjun Sarker | Avanos Medical | 58 | |
| Aviva McPherron | Orthofix Medical | N/A | |
Management Performance
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.0017 |
Accuray Incorporated Leadership Team
Elected by the shareholders, the Accuray Incorporated's board of directors comprises two types of representatives: Accuray Incorporated inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accuray. The board's role is to monitor Accuray Incorporated's management team and ensure that shareholders' interests are well served. Accuray Incorporated's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accuray Incorporated's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xavier Misouard, President Region | ||
| Melanie Gebauer, Vice Resources | ||
| GS Jha, Global Officer | ||
| Jesse Chew, Chief VP | ||
| Sandeep Chalke, Interim Officer | ||
| Nancy Hiller, President Region | ||
| Jim Dennison, Quality Regulatory | ||
| John Dunn, Chief President | ||
| Todd Brown, Senior Service | ||
| Joshua Levine, CEO and President and Director | ||
| JeanPhilippe Pignol, Chief VP | ||
| Franco Palomba, Chief VP | ||
| Patrick Spine, Sr Officer | ||
| Melanie Rivers, Chief VP | ||
| Ken Mobeck, VP Relations | ||
| Juki Hozumi, President Region | ||
| Suzanne MBA, CEO President | ||
| MD MBA, Senior Officer | ||
| Mu Lee, Senior Development | ||
| Gina Corradetti, Chief VP | ||
| Beth Kaplan, Public Director | ||
| Michael Hoge, Senior Operations | ||
| Roger Cao, President REGION | ||
| Ali Pervaiz, Interim CFO | ||
| Jesse JD, Chief VP |
Accuray Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Accuray Incorporated a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.0017 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 373.84 M | ||||
| Shares Outstanding | 100.56 M | ||||
| Shares Owned By Insiders | 2.82 % | ||||
| Shares Owned By Institutions | 62.58 % | ||||
| Number Of Shares Shorted | 3.6 M | ||||
| Price To Earning | 44.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.